Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model. - Wikidata - wikimedia - TriplyDB

Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model.

Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model.

http://www.wikidata.org/entity/Q37378034

about

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries.Performance of BRCA1/2 mutation prediction models in male breast cancer patients.Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.

P2860

Q30238753-BCC267CD-01FB-4793-A4BB-1FA888251ABA Q37524981-0F4140E0-6F62-4306-89BF-E5BED64B6868 Q38721663-86213342-2C5F-4019-8A8D-FABF826B0B6B Q38739022-C62866A1-71AB-4BCD-8B85-BD8C68FA69DF Q39263736-D4508BE6-FCCF-493F-BD1B-5A71230F271B Q54950358-925C4717-9C60-40ED-A1E2-9D31AE20C9D6 Q55207798-756873E3-881A-4A05-81AF-473ADC572335

P2860

Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model.

http://www.wikidata.org/entity/Q37378034

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Incorporating truncating varia ...... ICEA breast cancer risk model.

@en

Incorporating truncating varia ...... ICEA breast cancer risk model.

@nl

type

label

Incorporating truncating varia ...... ICEA breast cancer risk model.

@en

Incorporating truncating varia ...... ICEA breast cancer risk model.

@nl

prefLabel

Incorporating truncating varia ...... ICEA breast cancer risk model.

@en

Incorporating truncating varia ...... ICEA breast cancer risk model.

@nl

P1433

Q37378034-39285D15-35AC-4FE3-83E9-BC950B288478

P1476

Q37378034-BA613E93-8114-48D2-BFEC-90BC7E199927

P2093

Q37378034-2B911411-56C7-4117-B889-BCEF3768431D

Q37378034-2D7B9CB7-6E55-4129-BD00-B7C21F2ED74B

Q37378034-E043B6C8-F1C1-4BCA-BDDD-46B744FB010F

P2860

Q37378034-02FA6E37-81BA-485A-9DCE-0D001C7DE65C

Q37378034-06A7E49D-FF11-4EFD-A52D-3AC0C9279FAA

Q37378034-08DEA5A0-4900-4C1A-841A-22A4ABDF7A6B

Q37378034-0EB292FA-5E81-4239-956C-39388DD738D3

Q37378034-166A6790-F1DC-40FD-8378-DB4100E18F32

Q37378034-30CC986E-C2A5-4184-823A-F28C9CF6CC29

Q37378034-35379E5B-B51B-4B7F-9B52-A94D28CC597F

Q37378034-379FE7A1-E2FF-4B1D-BBED-7FA9EE8E7BA3

Q37378034-395F1F12-8B51-4E89-A1AB-9E04B4DBA6CD

Q37378034-46975031-0B07-4268-A966-17D6FDFE231D

P2888

Q37378034-99C6C8A2-894D-4651-B839-235033FB21E8

P304

Q37378034-44E39957-74BA-4F32-AC86-61AE07AE9616

P31

Q37378034-E26EA6CD-1A04-40EF-B227-2D0C33D9101C

P356

Q37378034-2E4A9FA9-CA1D-48A5-A340-5EC9F23AFC47

P407

Q37378034-C1B808D7-B119-4B8D-9869-7B1F8BD30615

P433

Q37378034-463CC134-8C87-4A59-8CCA-98BA933CCD81

P478

Q37378034-B117AC4B-4D77-434C-AAA0-EE23E51A61F7

P50

Q37378034-043E09A7-7F70-415C-8140-AD969FC56222

Q37378034-72278812-1A43-4AC8-9B65-E75BA22585F1

Q37378034-75E21AF7-FF20-4F0D-A195-3BF5EEFDA045

Q37378034-E56575D5-9567-44D2-9B7C-B3C34088EC90

P577

Q37378034-B2EE1771-1467-48DE-A1AC-0B7EE629497E

P698

Q37378034-E1AC8ACA-B12C-4651-9B49-0A45BA0B5A2D

P932

Q37378034-937C26D7-08F5-4D80-BEE2-6777FC972D33

P356

P1433

Genetics in Medicine

P1476

Incorporating truncating varia ...... ICEA breast cancer risk model.

@en

P2093

Alex P Cunningham

http://www.w3.org/2001/XMLSchema#string

Andrew J Lee

http://www.w3.org/2001/XMLSchema#string

Marc Tischkowitz

http://www.w3.org/2001/XMLSchema#string

P2860

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

Large-scale genotyping identifies 41 new loci associated with breast cancer risk.

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

Gene-gene interactions in breast cancer susceptibility.

Incorporating tumour pathology information into breast cancer risk prediction algorithms.

Breast-cancer risk in families with mutations in PALB2

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

P2888

P304

1190-1198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GIM.2016.31

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Douglas F. Easton

Paul D P Pharoah

Antonis C Antoniou

P577

2016-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27464310

http://www.w3.org/2001/XMLSchema#string

P932

5086091

http://www.w3.org/2001/XMLSchema#string